Skip to content

Rebiject II

by Ares Trading SA Switzerland EUDAMED

Ref U6722308, U6722306Model Rebiject II

EMDN A99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number4054839Rebiject2DD Basic UDI-DIDate4 Oct 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
Rebiject II, U6722308, U6722306
Primary DI / UDI-DI
04065266543407, 04065266543384
Basic UDI-DI
4054839Rebiject2DD
Direct Marketing DI
04065272560788
EMDN Code
A99 Devices for administration, withdrawal and collection - other
Device Class
Class IIa
Market of Registration
Romania
Italy

Manufacturer details

EUDAMED SRN
CH-MF-000021799
Authorised representative
Merck Healthcare KGaA DE-AR-000007181

Other devices from Ares Trading SA

See all devices from Ares Trading SA →

Properties & raw data

Show properties, registry sources and raw records
  • Administering Medicine
Other properties (12)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (2)

  • EUDAMED cdabfb8f-4c7f-4dc2-98e1-85813008598f 61 fields · synced 22 Oct 2026
  • EUDAMED 83076265-fe16-473f-b6b1-79650e13a984 61 fields · synced 19 May 2026